Clinical efficacy and safety of the BAT1706 (proposed bevacizumab biosimilar) compared with reference bevacizumab in patients with advanced nonsquamous NSCLC: A randomized, double-blind, phase III study.

Simple item page
dc.contributor.authorChen, Likun
dc.contributor.authorTrukhin, Dmytro
dc.contributor.authorKolesnik, Oleksii
dc.contributor.authorDavid Gomez Rangel, Jose David
dc.contributor.authorCil, Timucin
dc.contributor.authorLi, Xingya
dc.contributor.authorCicin, Irfan
dc.contributor.authorKobziev, Oleh
dc.contributor.authorShen, Yihong
dc.contributor.authorLiu, Zhihua
dc.contributor.authorOleksandr, Ivashchuk
dc.contributor.authorOzyilkan, Ozgur
dc.contributor.authorIgor, Bondarenko
dc.contributor.authorUrsol, Grygorii
dc.contributor.authorChen, Jun
dc.contributor.authorOleksandr, Kostiuk
dc.contributor.authorChen, Zhendong
dc.contributor.authorZhang, Helong
dc.contributor.authorTural, Deniz
dc.contributor.authorZhang, Li
dc.date.accessioned2022-11-04T10:35:29Z
dc.date.available2022-11-04T10:35:29Z
dc.date.issued2022
dc.identifier.issn0732-183Xen_US
dc.identifier.issue16en_US
dc.identifier.urihttp://hdl.handle.net/11727/8007
dc.identifier.volume40en_US
dc.identifier.wos000863680302228en_US
dc.language.isoengen_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleClinical efficacy and safety of the BAT1706 (proposed bevacizumab biosimilar) compared with reference bevacizumab in patients with advanced nonsquamous NSCLC: A randomized, double-blind, phase III study.en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos İndeksli Yayınlar Koleksiyonu
Wos Kapalı Erişimli Yayınlar